Breaking News Instant updates and real-time market news.

DVA

DaVita

$68.00

0.07 (0.10%)

12:05
05/23/18
05/23
12:05
05/23/18
12:05

DaVita call volume above normal and directionally bullish

Bullish option flow detected in DaVita with 8,983 calls trading, 8x expected, and implied vol increasing over 1 point to 20.04%. Jun-18 70 calls and Jan-19 75 calls are the most active options, with total volume in those strikes near 8,600 contracts. The Put/Call Ratio is 0.00. Earnings are expected on August 1st.

DVA DaVita
$68.00

0.07 (0.10%)

01/04/18
BOFA
01/04/18
UPGRADE
BOFA
Buy
DaVita upgraded to Buy, named a Top Pick at BofA/Merrill
BofA/Merrill analyst Kevin Fischbeck upgraded DaVita to Buy from Neutral, named its a Top Pick, and raised its price target to $85 from $75. Fischbeck thinks DaVita's commercial mix and pricing are stabilizing, which could prove to be a tailwind given conservative initial guidance, and the sale of DaVita Medical Group proceeds can be used for share repurchases, investments, and debt repayment. Further, the analyst sees upside from the shift to MA, tax reform, and EPO savings.
01/11/18
BOFA
01/11/18
NO CHANGE
Target $92
BOFA
Buy
DaVita price target raised to $92 from $85 at BofA/Merrill
BofA/Merrill analyst Kevin Fischbeck raised DaVita's price target to $92 from $85 and reiterated a Buy rating on a stabilizing commercial outlook with potential share repurchase upside. Fischbeck raised estimates to reflect tax reform, the Davita Medical Group sale, and capital deployment.
01/12/18
BARD
01/12/18
NO CHANGE
Target $95
BARD
Outperform
DaVita price target raised to $95 from $82 at Baird
Baird analyst Whit Mayo raised his price target on DaVita to $95 from $82 based on tax reform and its stock buyback pushing its earning higher. He said DaVita remains a Best Idea for 2018 as he sees core EBITDA growth inflecting into 2019 and diminishing CPA-related risks. Mayo reiterated his Outperform rating on DaVta shares.
05/16/18
MSCO
05/16/18
NO CHANGE
Target $200
MSCO
Overweight
Epogen biosimilar should have little impact on Amgen, says Morgan Stanley
After the FDA approved Retacrit, Pfizer's (PFE) biosimilar version of Amgen's (AMGN) Epogen, Morgan Stanley analyst Matthew Harrison said he does not see significant impact to his forecasts due to the news, noting that Amgen has already discounted Epogen net selling price significantly to secure an extended supply agreement with DaVita (DVA). Amgen renegotiated the supply agreement in early 2017 and the vast majority of Epogen volume is from DaVita, added Harrison, who maintains an Overweight rating and $200 price target on Amgen shares.

TODAY'S FREE FLY STORIES

11:25
10/19/18
10/19
11:25
10/19/18
11:25
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

11:25
10/19/18
10/19
11:25
10/19/18
11:25
Conference/Events
RBC Capital refiners and E&P analysts to hold a luncheon meeting »

Refiners & E&P…

VLKAY

Volkswagen

$0.00

(0.00%)

11:24
10/19/18
10/19
11:24
10/19/18
11:24
Periodicals
VW starts construction on all-electric vehicle plant in China, Electrek says »

Volkswagen has begun…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$278.59

2.26 (0.82%)

11:23
10/19/18
10/19
11:23
10/19/18
11:23
Periodicals
Mnuchin to attend Saudi anti-terror financing meeting, Washington Post says »

Treasury Secretary Steven…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.59

2.26 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLT

Hilton

$71.80

-0.28 (-0.39%)

11:20
10/19/18
10/19
11:20
10/19/18
11:20
Options
Call buyers in Hilton ahead of earnings next week »

Call buyers in Hilton…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

11:20
10/19/18
10/19
11:20
10/19/18
11:20
General news
Treasury Option Action: a round of put positioning on bonds »

Treasury Option Action: a…

APHB

AmpliPhi

$0.34

0.0142 (4.38%)

11:19
10/19/18
10/19
11:19
10/19/18
11:19
Recommendations
AmpliPhi analyst commentary  »

AmpliPhi price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UCFC

United Community Financial

$9.40

0.03 (0.32%)

11:18
10/19/18
10/19
11:18
10/19/18
11:18
Hot Stocks
Breaking Hot Stocks news story on United Community Financial »

FJ Capital reports 5.03%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUVA

NuVasive

$61.95

-6.29 (-9.22%)

11:17
10/19/18
10/19
11:17
10/19/18
11:17
Recommendations
NuVasive analyst commentary  »

Piper remains buyer of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 27

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
10/19/18
10/19
11:17
10/19/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
10/19/18
10/19
11:16
10/19/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$8.44

-0.065 (-0.76%)

, GM

General Motors

$31.17

0.09 (0.29%)

11:15
10/19/18
10/19
11:15
10/19/18
11:15
OnTheFly
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's top…

F

Ford

$8.44

-0.065 (-0.76%)

GM

General Motors

$31.17

0.09 (0.29%)

ROKU

Roku

$57.13

0.14 (0.25%)

DIG

The Walt Disney Internet Group

$39.45

0.28 (0.71%)

EBAY

eBay

$28.84

-2.72 (-8.62%)

PYPL

PayPal

$84.80

7.3 (9.42%)

TSLA

Tesla

$261.50

-2.35 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 07

    Nov

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

  • 13

    Dec

  • 03

    Mar

11:15
10/19/18
10/19
11:15
10/19/18
11:15
General news
Breaking General news story  »

Atlanta Federal Reserve…

LOGC

LogicBio Therapeutics

$0.00

(0.00%)

11:13
10/19/18
10/19
11:13
10/19/18
11:13
Syndicate
LogicBio Therapeutics open at $10.71, IPO priced at $10.00 per share »

LogicBio Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

ACRX

AcelRx

$4.10

-0.05 (-1.20%)

11:10
10/19/18
10/19
11:10
10/19/18
11:10
Options
AcelRx attracts downside put buying »

AcelRx attracts downside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

CAT

Caterpillar

$133.66

-1.25 (-0.93%)

11:00
10/19/18
10/19
11:00
10/19/18
11:00
Options
Earnings hedge opened in Caterpillar »

Earnings hedge opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

STN

Stantec

$24.46

0.09 (0.37%)

10:59
10/19/18
10/19
10:59
10/19/18
10:59
Upgrade
Stantec rating change  »

Stantec upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$43.10

-0.17 (-0.39%)

10:55
10/19/18
10/19
10:55
10/19/18
10:55
Options
Etsy put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

10:55
10/19/18
10/19
10:55
10/19/18
10:55
General news
Existing home sales were much weaker than expected »

Existing home sales were…

SWI

SolarWinds

$0.00

(0.00%)

10:49
10/19/18
10/19
10:49
10/19/18
10:49
Syndicate
Breaking Syndicate news story on SolarWinds »

SolarWinds opens at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

SWI

SolarWinds

$0.00

(0.00%)

10:47
10/19/18
10/19
10:47
10/19/18
10:47
Syndicate
Breaking Syndicate news story on SolarWinds »

SolarWinds indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

MAT

Mattel

$14.50

0.31 (2.18%)

10:45
10/19/18
10/19
10:45
10/19/18
10:45
Options
Mattel call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 03

    Mar

TPIC

TPI Composites

$25.25

0.2 (0.80%)

10:37
10/19/18
10/19
10:37
10/19/18
10:37
Conference/Events
TPI Composites management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

KLIC

Kulicke & Soffa

$21.53

0.12 (0.56%)

10:36
10/19/18
10/19
10:36
10/19/18
10:36
Conference/Events
Kulicke & Soffa management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

HBAN

Huntington Bancshares

$14.37

0.17 (1.20%)

10:36
10/19/18
10/19
10:36
10/19/18
10:36
Conference/Events
Huntington Bancshares management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.